"Consultório médico"

During the past decade, Praxis pesquisa médica conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 5 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 5 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Praxis pesquisa médica" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Agios Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Praxis pesquisa médica" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Beneficência Portuguesa de São Paulo" with 1 trials as a collaborator, "Brazilian Research In Intensive Care Network" with 1 trials as a collaborator, "Hospital Alemão Oswaldo Cruz" with 1 trials as a collaborator and "Hospital Israelita Albert Einstein" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Praxis pesquisa médica" are "Crohn's Disease" (4 trials), "COVID-19" (3 trials), "Crohn Disease" (3 trials), "Heart Failure" (2 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Praxis pesquisa médica" in a lesser frequency.

Most popular intervention types in "Praxis pesquisa médica" are "Drug" (20 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Guselkumab" (3 trials), "Empagliflozin" (2 trials), "Etrolizumab" (2 trials) and "Golimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Praxis pesquisa médica" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Praxis pesquisa médica". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Praxis pesquisa médica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxis pesquisa médica, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".